Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Stauch

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Journal of Thrombosis and Haemostasis : JTH|July 4, 2026
RNA Sequencing Indicates Distinct Platelet Transcriptomic Changes in Immune ThrombocytopeniaJulia-Annabell Georgi, Marita Hartwig, Ulrike Anne Friedrich, et al.
Healthcare (Basel, Switzerland)|January 11, 2024
German Porphyria Registry (PoReGer)-Background and SetupLea Gerischer, Mona Mainert, Nils Wohmann, et al.
Oncology Research and Treatment|December 26, 2022
[Expertenreport Immunthrombozytopenie - Aktuelle Diagnostik und Therapie]Axel Matzdorff, Sonja R Alesci, Johanna Gebhart, et al.
Oncology Research and Treatment|February 14, 2023
Expert Report on Immune Thrombocytopenia: Current Diagnostics and Treatment - Recommendations from an Expert Group from Austria, Germany, and SwitzerlandAxel Matzdorff, Sonja R Alesci, Johanna Gebhart, et al.
Annals of Hematology|May 23, 2026
Value of functional iron parameters in diagnostic re-assessment of MPN: refinement of iron-deficiency markers by zinc protoporphyrin (ZPP)Kirsi Manz, Myriam Kobrosly, Carl C Crodel, et al.
Haematologica|June 26, 2025
Use of second-line and beyond maintenance therapies in adult patients with primary immune thrombocytopenia in Europe: a parallel study of six prospective multicenter national registriesGuillaume Moulis, Frederick Chen, Giuseppe Carli, et al.
The New England Journal of Medicine|December 9, 2025
Ianalumab plus Eltrombopag in Immune ThrombocytopeniaAdam Cuker, Thomas Stauch, Nichola Cooper, et al.
British Journal of Haematology|January 5, 2026
High pretreatment peripheral blood T-cell receptor clonality as a predictor of prolonged response in immune thrombocytopenia to the British Journal of HaematologyPaul Schmidt-Barbo, Christoph Schultheiss, Annaïse J Jauch, et al.
British Journal of Haematology|January 7, 2026
Efficacy and safety of eltrombopag in combination with dexamethasone as first-line treatment in adult patients with newly diagnosed immune thrombocytopenia for the British Journal of HaematologyAnnaïse J Jauch, Paul Schmidt-Barbo, Christoph Schultheiss, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Journal of Thrombosis and Haemostasis : JTH|July 4, 2026
RNA Sequencing Indicates Distinct Platelet Transcriptomic Changes in Immune ThrombocytopeniaJulia-Annabell Georgi, Marita Hartwig, Ulrike Anne Friedrich, et al.
Healthcare (Basel, Switzerland)|January 11, 2024
German Porphyria Registry (PoReGer)-Background and SetupLea Gerischer, Mona Mainert, Nils Wohmann, et al.
Oncology Research and Treatment|December 26, 2022
[Expertenreport Immunthrombozytopenie - Aktuelle Diagnostik und Therapie]Axel Matzdorff, Sonja R Alesci, Johanna Gebhart, et al.
Oncology Research and Treatment|February 14, 2023
Expert Report on Immune Thrombocytopenia: Current Diagnostics and Treatment - Recommendations from an Expert Group from Austria, Germany, and SwitzerlandAxel Matzdorff, Sonja R Alesci, Johanna Gebhart, et al.
Annals of Hematology|May 23, 2026
Value of functional iron parameters in diagnostic re-assessment of MPN: refinement of iron-deficiency markers by zinc protoporphyrin (ZPP)Kirsi Manz, Myriam Kobrosly, Carl C Crodel, et al.
Haematologica|June 26, 2025
Use of second-line and beyond maintenance therapies in adult patients with primary immune thrombocytopenia in Europe: a parallel study of six prospective multicenter national registriesGuillaume Moulis, Frederick Chen, Giuseppe Carli, et al.
The New England Journal of Medicine|December 9, 2025
Ianalumab plus Eltrombopag in Immune ThrombocytopeniaAdam Cuker, Thomas Stauch, Nichola Cooper, et al.
British Journal of Haematology|January 5, 2026
High pretreatment peripheral blood T-cell receptor clonality as a predictor of prolonged response in immune thrombocytopenia to the British Journal of HaematologyPaul Schmidt-Barbo, Christoph Schultheiss, Annaïse J Jauch, et al.
British Journal of Haematology|January 7, 2026
Efficacy and safety of eltrombopag in combination with dexamethasone as first-line treatment in adult patients with newly diagnosed immune thrombocytopenia for the British Journal of HaematologyAnnaïse J Jauch, Paul Schmidt-Barbo, Christoph Schultheiss, et al.
Pageof 3